<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6990</article-id>
      <article-id pub-id-type="doi">10.51847/kRuuDhFKs0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>From Digital Health Signals to Medication Decisions: A Conceptual Framework for Managing Temporal Drift, Missingness, and Intervention Feedback in Artificial Intelligence–Enabled Longitudinal Pharmaceutical Care</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Clarke</surname>
                <given-names>Amelia</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Mendoza</surname>
                <given-names>Carlos</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Al-Rashid</surname>
                <given-names>Hassan</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Schmidt</surname>
                <given-names>Julia</given-names>
              </name>
                              <xref rid="aff4" ref-type="aff">4</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Digital Health and Longitudinal Pharmaceutical Care, University of Melbourne, Melbourne, Australia.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Health Data Science and Pharmaceutical Care, Universidad de los Andes, Bogota, Colombia.
          </aff>
                  <aff id="aff3">
            <label>3</label>Department of AI and Pharmaceutical Decision Science, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.
          </aff>
                  <aff id="aff4">
            <label>4</label>Department of Pharmaceutical Data Science and Digital Therapeutics, University of St. Gallen, St. Gallen, Switzerland.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="amelia.clarke@unimelb.edu.au">amelia.clarke@unimelb.edu.au</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>28</day>
        <month>10</month>
        <year>2026</year>
      </pub-date>
      <volume>17</volume>
      <issue>5</issue>
      <fpage>74</fpage>
      <lpage>81</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Digital health technologies increasingly produce continuous or frequently repeated observations that could inform medication initiation, titration, monitoring, adherence support, and treatment review. Yet longitudinal availability does not guarantee longitudinal interpretability. A change in a wearable, mobile, or remotely acquired signal may reflect biological evolution, treatment response, altered behavior, sensor or platform change, data-quality deterioration, incomplete observation, or the downstream consequences of an earlier clinical intervention. Artificial intelligence can amplify this ambiguity when models treat incoming observations as comparable with historical training data and independent of prior actions. This article develops a conceptual account of how digital health signals should be translated into medication decisions when temporal drift, missingness, and intervention feedback coexist. The central proposition is that medication-oriented inference should distinguish changes in patient state from changes in the measurement system, observation process, model state, and intervention history before a longitudinal trajectory is treated as clinically actionable. The analysis further separates model updating from clinical escalation: recalibration, additional measurement, clinician review, model withholding, and retraining address different failure mechanisms and should not be treated as interchangeable responses to declining confidence. The resulting framework is intended to support longitudinal pharmaceutical care without assuming that repeated digital measurements are stationary, complete, or unaffected by previous therapeutic decisions.</p>
      </abstract>
      <kwd-group>
                <kwd>Digital health</kwd>
                <kwd>Artificial intelligence</kwd>
                <kwd>Medication management</kwd>
                <kwd>Temporal drift</kwd>
                <kwd>Missing data</kwd>
                <kwd>Longitudinal pharmaceutical care</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>
